MHMartin Hale
Martin Hale
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Martin Hale has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
A. Khan
Northwest Clinical Research Center, Bellevue, WA, USA; Duke University Medical Center, Durham, NC, USA
1 shared publicationChris Dvergsten
1 shared publicationIulia Cristina Tudor
ALZA Corporation, Mountain View, California, USA
1 shared publicationJohn Thipphawong
ALZA Corporation, Mountain View, California, USA
1 shared publicationJoseph Gimbel
1 shared publicationM. Kutch
Applied Clinical Intelligence, LLC, Bala Cynwyd, PA, USA
1 shared publication
Latest Publications
- 30 April 2010
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 26 (6) , 1505-1518
Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain
(2010). Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Current Medical Research and Opinion: Vol. 26, No. 6, pp. 1505-1518.
- 30 April 2010
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 26 (6) , 1505-1518
Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain
(2010). Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Current Medical Research and Opinion: Vol. 26, No. 6, pp. 1505-1518.
- 1 May 2007
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (5) , 874-888
Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis
- 1 May 2007
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (5) , 874-888
Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis
- 1 January 2005
- Published by Elsevier in The Journal of Pain
- Vol. 6 (1) , 21-28
Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study
- 1 January 2005
- Published by Elsevier in The Journal of Pain
- Vol. 6 (1) , 21-28
Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study